Loading clinical trials...

Effectiveness of A Stigma Directed Interventional Program in Schizophrenia | Clinical Trials | Clareo Health

COMPLETEDNA

Effectiveness of A Stigma Directed Interventional Program in Schizophrenia

NCT03930225•Mansoura University

Summary

randomized controlled study measuring the effectiveness of Stigma focused intervention in patients suffering from Schizophrenia

Detailed Description

Effectiveness of A Stigma Directed Intervention Program in Schizophrenia It is a Randomized Controlled trial that aims at: * Assessment of the relationship between self- stigma and 1. Family burden on the caregiver (Family member). 2. Medication adherence by patients. * Assessment of the effectiveness of the family incorporation in the process of psychoeducation delivered to the patients suffering from Schizophrenia on the self-stigma and family burden of patients with Schizophrenia patients. The study will be held in Mansoura University hospital Psychiatry department and will include 80 Egyptian patients with Schizophrenia or Schizoaffective disorder will be recruited from Psychiatry department of Mansoura University Hospital

Eligibility

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Patients meet the diagnosis of schizophrenia or schizoaffective disorder according to DSM5.The clinical condition is stabilized.
•2. Age range between 18 to 50 years.
•3. Male and female sexes are included.
•4. Availability of close relative in direct contact with the patient.
•1. Primary caregiver and the family member share household with patient.
•2. No history of receiving treatment of psychiatric disorders.
•3. No history of serious head trauma.

Exclusion Criteria

•1. Co morbid substance abuse or dependence disorder.
•2. Co morbid intellectual disability.
•3. Co morbid chronic medical or neurological condition or history of serious head trauma.
•Sever physical illness that hinders their participation- -

Locations (1)

Mansoura University Psychiatry Department

Al Mansurah, Dakahlya, Egypt

Key Dates

Start Date

April 16, 2019

Primary Completion Date

June 30, 2024

Completion Date

November 2, 2024

Last Updated

July 10, 2025

Enrollment

ACTUAL participants

Conditions

SchizophreniaStigma, Social

Interventions

Stigma Directed Psycho-educational Intervention program

BEHAVIORAL

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

NCT07455929

Psychotic DisordersSchizophrenia Spectrum Disorders

View study

RECRUITING

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

NCT06740383

Schizophrenia Spectrum and Other Psychotic DisordersSchizophrenia+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effectiveness of A Stigma Directed Interventional Program in Schizophrenia

Inclusion Criteria

Exclusion Criteria

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques

Brain Stimulation to the Hippocampus in Schizophrenia